Estrogen linked to lower Alzheimer's risk

Gastroenterologist Dr. Will Bulsiewicz discusses a new Stanford Medicine study linking estrogen-based hormone therapy to lower Alzheimer's and dementia risks.

Stanford Medicine research reveals that estrogen-based menopausal hormone therapy is linked to a 35% lower risk of Alzheimer's disease. Gastroenterologist Dr. Will Bulsiewicz breaks down these findings and analyzes brain scan data.